{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:26:15Z","timestamp":1786998375840,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"TFDA","award":["102-TFDA-P-033"],"award-info":[{"award-number":["102-TFDA-P-033"]}]},{"name":"TFDA","award":["103-TFDA-P-034"],"award-info":[{"award-number":["103-TFDA-P-034"]}]},{"name":"TFDA","award":["104-TFDA-P-034"],"award-info":[{"award-number":["104-TFDA-P-034"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.yrtph.2015.09.020","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T15:28:00Z","timestamp":1443108480000},"page":"947-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The evolution and challenges for the international harmonization of\u00a0the regulation of pharmaceutical excipients in Taiwan"],"prefix":"10.1016","volume":"73","author":[{"given":"Lin-Chau","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Jou","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Churn-Shiouh","family":"Gau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2015.09.020_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsps.2013.06.003","article-title":"Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients","volume":"23","author":"Abdellah","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.yrtph.2015.09.020_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yrtph.2009.09.015","article-title":"The safety of chitosan as a pharmaceutical excipient","volume":"56","author":"Baldrick","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.09.020_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamainternmed.2014.19","article-title":"Lessons learned from yet another episode of diethylene glycol poisoning. It happened before and it happened again","volume":"174","author":"Brent","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.yrtph.2015.09.020_bib4","first-page":"23","article-title":"Excipient risk analysis: a new era?","volume":"6","author":"Carlin","year":"2015","journal-title":"J.\u00a0Excip. Food Chem."},{"key":"10.1016\/j.yrtph.2015.09.020_bib5","series-title":"Notice to Applicants. Volume 3B. Guidelines. Medicinal Products for Human Use. Safety, Environment and Information. Excipients in the Label and Package Leaflet of Medicinal Products for Human Use","author":"European Commission (EC)","year":"2003"},{"key":"10.1016\/j.yrtph.2015.09.020_bib6","series-title":"EudraLex: the Rules Governing Medicinal Products in the European Union. EU Guidelines to Good Manufacturing Practice. Medicinal Products for Human and Veterinary Use","author":"European Commission (EC)","year":"2010"},{"key":"10.1016\/j.yrtph.2015.09.020_bib7","unstructured":"European Directorate for the Quality of Medicines & HealthCare. European Pharmacopoeia (EP), eighth ed."},{"key":"10.1016\/j.yrtph.2015.09.020_bib8","series-title":"Guideline on Excipients in the Dossier for Application for Marketing Authorisation of a Medicinal Product","author":"European Medicines Agency (EMA)","year":"2007"},{"key":"10.1016\/j.yrtph.2015.09.020_bib9","series-title":"Questions and Answers on Benzoic Acid and Benzoates in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib10","series-title":"Questions and Answers on Benzyl Alcohol in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib11","series-title":"Questions and Answers on Ethanol in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib12","series-title":"Questions and Answers on Benzalkonium Chloride in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib13","series-title":"Questions and Answers on Wheat Starch Containing Gluten in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00 Rev. 1), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib14","series-title":"Questions and Answers on Cyclodextrins in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00 Rev. 1), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib15","series-title":"Background Review for Cyclodextrins Used as Excipients. In the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00 Rev. 1), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib16","series-title":"Questions & Answers on Propylene Glycol and Esters in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00 Rev.1), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib17","series-title":"Background Review for the Excipient Propylene Glycol. In the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (CPMP\/463\/00 Rev. 1), Draft","author":"European Medicines Agency (EMA)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib18","series-title":"Guidelines of 19 March 2015 on the Formalised Risk Assessment for Ascertaining the Appropriate Good Manufacturing Practice for Excipients of Medicinal Products for Human Use (Text with EEA Relevance) (2015\/C 95\/02)","author":"European Union (EU)","year":"2015"},{"key":"10.1016\/j.yrtph.2015.09.020_bib19","series-title":"ICH Harmonised Tripartite Guideline. Quality Risk Management. Q9","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)","year":"2005"},{"key":"10.1016\/j.yrtph.2015.09.020_bib20","series-title":"ICH Harmonised Tripartite Guideline. Pharmaceutical Development. Q8(R2)","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)","year":"2009"},{"key":"10.1016\/j.yrtph.2015.09.020_bib21","series-title":"ICH Harmonised Tripartite Guideline. The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality \u2013 M4Q(R1). Quality Overall Summary of Module 2. Module 3: Quality","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)","year":"2002"},{"key":"10.1016\/j.yrtph.2015.09.020_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jconrel.2014.04.047","article-title":"Designer lipids for drug delivery: from heads to tails","volume":"190","author":"Kohli","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.yrtph.2015.09.020_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.23810","article-title":"A\u00a0quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes","volume":"103","author":"Kushner","year":"2014","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.yrtph.2015.09.020_bib24","series-title":"Guidelines on the Drug Stability Study","author":"Ministry of Health and Welfare, Taiwan","year":"2005"},{"key":"10.1016\/j.yrtph.2015.09.020_bib25","series-title":"Announcement 0981401222","author":"Ministry of Health and Welfare, Taiwan","year":"2009"},{"key":"10.1016\/j.yrtph.2015.09.020_bib26","series-title":"Taiwan Pharmacopoeia","author":"Ministry of Health and Welfare, Taiwan","year":"2011"},{"key":"10.1016\/j.yrtph.2015.09.020_bib27","series-title":"Announcement 1011405725","author":"Ministry of Health and Welfare, Taiwan","year":"2012"},{"key":"10.1016\/j.yrtph.2015.09.020_bib28","series-title":"Announcement 1021452529","author":"Ministry of Health and Welfare, Taiwan","year":"2013"},{"key":"10.1016\/j.yrtph.2015.09.020_bib29","series-title":"Announcement 1021453148","author":"Ministry of Health and Welfare, Taiwan","year":"2013"},{"key":"10.1016\/j.yrtph.2015.09.020_bib30","series-title":"Announcement 1031412373","author":"Ministry of Health and Welfare, Taiwan","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib31","series-title":"Announcement 1031412392","author":"Ministry of Health and Welfare, Taiwan","year":"2015"},{"key":"10.1016\/j.yrtph.2015.09.020_bib32","series-title":"Regulations for Registration of Medicinal Products","author":"Ministry of Health and Welfare, Taiwan","year":"2015"},{"key":"10.1016\/j.yrtph.2015.09.020_bib33","first-page":"18","article-title":"Industry advances on excipient safety. A new quality standard bolsters a stand-in for regulators on an important part of the drug supply chain","volume":"93","author":"Mullin","year":"2015","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.yrtph.2015.09.020_bib34","series-title":"Guide to Good Manufacturing Practice for Medicinal Products","author":"Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Co-operation Scheme (PIC Scheme) (PIC\/S)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.09.020_bib35","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.yrtph.2015.09.020_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1208\/s12248-014-9646-z","article-title":"Effect of excipients on the particle size of precipitated pioglitazone in the gastrointestinal tract: impact on bioequivalence","volume":"16","author":"Sugita","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.yrtph.2015.09.020_bib37","unstructured":"US Code of Federal Regulations Title 21\u2013Food and Drugs. Chapter I\u2013Food and Drug Administration. Department of Health and Human Services. Subchapter C\u2013Drugs: General. Part 201 Labeling."},{"key":"10.1016\/j.yrtph.2015.09.020_bib38","unstructured":"US Code of Federal Regulations Title 21\u2013Food and Drugs. Chapter I\u2013Food and Drug Administration. Department of Health and Human Services. Subchapter C\u2013Drugs: General. Part 210 Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; general."},{"key":"10.1016\/j.yrtph.2015.09.020_bib39","unstructured":"US Code of Federal Regulations Title 21\u2013Food and Drugs. Chapter I\u2013Food and Drug Administration. Department of Health and Human Services. Subchapter C\u2013Drugs: General. Part 211 Current good manufacturing practice for finished pharmaceuticals."},{"key":"10.1016\/j.yrtph.2015.09.020_bib40","series-title":"Guidance for Industry: M4Q: The CTD \u2013 Quality","author":"US Department of Health and Human Services, Food and Drug Administration (US FDA)","year":"2001"},{"key":"10.1016\/j.yrtph.2015.09.020_bib41","series-title":"Guidance for Industry: Liposome Drug Products. Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation, Draft","author":"US Department of Health and Human Services, Food and Drug Administration (US FDA)","year":"2002"},{"key":"10.1016\/j.yrtph.2015.09.020_bib42","series-title":"Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients","author":"US Department of Health and Human Services, Food and Drug Administration (US FDA)","year":"2005"},{"key":"10.1016\/j.yrtph.2015.09.020_bib43","series-title":"Guidance for Industry: Testing of Glycerin for Diethylene Glycol","author":"US Department of Health and Human Services, Food and Drug Administration (US FDA)","year":"2007"},{"key":"10.1016\/j.yrtph.2015.09.020_bib44","series-title":"US Food and Drug Administration Safety and Innovation Act (FDASIA)","year":"2012"},{"key":"10.1016\/j.yrtph.2015.09.020_bib45","unstructured":"US Department of Health and Human Services, Food and Drug Administration (US FDA) Inactive Ingredient Database. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.Cfm"},{"key":"10.1016\/j.yrtph.2015.09.020_bib46","unstructured":"US Department of Health and Human Services, Food and Drug Administration (US FDA). Generally Recognized as Safe (GRAS) Substances (SCOGS) Database. http:\/\/www.fda.gov\/food\/ingredientspackaginglabeling\/gras\/scogs\/ucm2006852.htm"},{"key":"10.1016\/j.yrtph.2015.09.020_bib47","unstructured":"US Pharmacopeial Convention. The United States Pharmacopeia and the National Formulary (USP 38\u2013NF 33)."},{"key":"10.1016\/j.yrtph.2015.09.020_bib48","first-page":"128","article-title":"The current situation of pharmaceutical excipients in China and the comparison in supervision at home and abroad","volume":"28","author":"Xiao","year":"2014","journal-title":"Chin. Pharm. Aff."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T02:58:47Z","timestamp":1537325927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230015300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0273230015300696"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.09.020","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolution and challenges for the international harmonization of\u00a0the regulation of pharmaceutical excipients in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}